The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
VEGZELMA bevacizumab 100 mg/ 4 mL solution for intravenous infusion, vial (398631)
ARTG Name
VEGZELMA bevacizumab 100 mg/ 4 mL solution for intravenous infusion, vial
Product name
VEGZELMA bevacizumab 100 mg/ 4 mL solution for intravenous infusion, vial
ARTG Date
Registration Type
Medicine
Therapeutic good type
Medicine
Ingredients
Bevacizumab
Licence category
RE
Licence status
A
Summary
Product Information
Consumer Medicine Information